Talking Cancer Blog: A Conversation with Holly Smithson, Athena CEO & Diversity Champion
Blog
Read More
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
Press Release
Read More
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
Press Release
Read More
NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer
Press Release
Read More
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
Press Release
Read More
NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences
Press Release
Read More